StonvexLoading…
StonvexStonvexStonvexCore line items from CCSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $88.47M | $349.70M | $262.63M | $174.86M |
Operating Income | $37.74M | $150.24M | $114.48M | $76.55M |
Net Income | $24.68M | $84.53M | $64.02M | $41.93M |
EPS (Diluted) | $1.30 | $4.35 | $3.29 | $2.14 |
Total Assets | $678.74M | $663.82M | $674.97M | $641.52M |
Total Liabilities | $656.74M | $650.04M | $677.61M | $668.00M |
Cash & Equivalents | $92.29M | $74.69M | $97.65M | $57.89M |
Free Cash Flow OCF − CapEx | $38.45M | $105.85M | $98.53M | $54.09M |
Shares Outstanding | 18.40M | 18.96M | 18.99M | 19.09M |